Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. buy Needham & Company LLC

Start price
€188.65
26.04.24 / 50%
Target price
€220.14
26.04.25
Performance (%)
6.81%
Price
€201.50
06.05.24
Summary
This prediction is currently active. With a performance of 6.81%, the BUY prediction by Needham___Company_LL for Resmed Inc. is trending in the right direction. This prediction currently runs until 26.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this prediction
Performance without dividends (%)
Name 1w
Resmed Inc. -1.079%
iShares Core DAX® -0.922%
iShares Nasdaq 100 0.371%
iShares Nikkei 225® 2.224%
iShares S&P 500 -0.026%

Comments by Needham___Company_LL for this prediction

In the thread Resmed Inc. diskutieren
Prediction Buy
Perf. (%) 6.81%
Target price 220.141
Change
Ends at 26.04.25

ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $224.00 to $236.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat

Stopped prediction by Needham___Company_LL for Resmed Inc.

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€177.75
01.04.24
€207.72
01.04.25
13.36%
06.05.24

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€173.80
25.01.24
€197.59
25.01.25
16.19%
06.05.24

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€143.10
06.09.23
-
06.09.24
41.44%
06.05.24